Journal of Heart and Lung Transplantation

Journal of Heart and Lung Transplantation
Title	Journal of Heart and Lung Transplantation
Discipline	Transplantation, Cardiology, Pulmonology
Editor	Mandeep R. Mehra
Publisher	Elsevier
Country	United States
History	1981–present
Frequency	Monthly
Openaccess	Hybrid
Impact	8.9
Impact-year	2022
Abbreviation	J. Heart Lung Transplant.
Website	https://www.jhltonline.org/
ISSN	1053-2498
EISSN	1557-3117
CODEN	JHLTCO
LCCN	91640614
OCLC	2244686

Journal of Heart and Lung Transplantation. It is the premier peer-reviewed medical journal dedicated to the field of advanced heart failure and lung transplantation. Published monthly by Elsevier, it serves as the official publication of the International Society for Heart and Lung Transplantation (ISHLT). The journal disseminates critical research on the medical, surgical, and psychosocial aspects of end-stage heart disease, end-stage lung disease, and advanced therapies including mechanical circulatory support.

History and scope

The journal was established in 1981, evolving from the proceedings of the annual meetings of the then-named International Society for Heart Transplantation. Its scope expanded significantly with the formal merger creating the International Society for Heart and Lung Transplantation in 1990, reflecting the growing clinical and scientific integration of thoracic transplantation disciplines. The publication's purview encompasses original clinical research, basic science investigations, and review articles related to the management of cardiomyopathy, pulmonary hypertension, donor organ procurement, immunosuppression, and infectious disease in transplant recipients. It also covers innovations in ventricular assist device technology and long-term outcomes research from major centers like Cedars-Sinai Medical Center and Cleveland Clinic.

Abstracting and indexing

The journal is extensively abstracted and indexed in major scientific databases, ensuring global dissemination of its content. It is covered by services including PubMed, MEDLINE, Scopus, and the Science Citation Index Expanded within the Web of Science platform. Its inclusion in these core resources, such as those curated by Clarivate and the National Library of Medicine, is essential for researchers at institutions like Johns Hopkins Hospital and the University of California, San Francisco to access its findings. The consistent indexing in these databases underscores its role as a foundational resource in the National Institutes of Health-funded research landscape.

Impact and metrics

As of the 2022 Journal Citation Reports, it holds an impact factor of 8.9, ranking it highly in categories such as "Transplantation" and "Cardiac & Cardiovascular Systems." This metric, calculated by Clarivate, reflects its high citation frequency and influence within the specialty. Other key metrics include its Scimago Journal Rank and CiteScore, which further attest to its scholarly impact. The journal's high Eigenfactor score indicates the broad reach of its published research among clinicians and scientists affiliated with organizations like the American Heart Association and the European Society of Cardiology.

Editorial board and policies

The journal is led by Editor-in-Chief Mandeep R. Mehra, a renowned cardiologist from Brigham and Women's Hospital. The international editorial board comprises leading experts from institutions worldwide, including Stanford University, Harefield Hospital, and University of Alberta. It adheres to rigorous peer-review policies and ethical publishing standards as outlined by the Committee on Publication Ethics (COPE). The journal offers a hybrid open access publishing model and requires all clinical trials to be registered in databases such as ClinicalTrials.gov prior to submission, in alignment with guidelines from the International Committee of Medical Journal Editors.

Notable articles and contributions

The journal has published numerous landmark studies that have shaped clinical practice. Seminal works include early reports on the use of cyclosporine in heart transplantation, pivotal trials for left ventricular assist device destination therapy, and consensus guidelines for the management of antibody-mediated rejection. It regularly features the annual reports from the International Society for Heart and Lung Transplantation Registries, which provide comprehensive global data on transplant volumes and outcomes. These contributions have directly informed protocols at major transplant networks and regulatory decisions by bodies like the Food and Drug Administration.

Related publications and society

It is inextricably linked to the activities of the International Society for Heart and Lung Transplantation, which also endorses related scholarly outputs such as the *ISHLT Monograph Series* and consensus statements. The society's annual meeting, held in locations like Washington, D.C. and Vienna, is a key forum for research later published in the journal. While it is the flagship publication, professionals in the field also frequently contribute to or consult other major journals like Circulation, the American Journal of Transplantation, and the European Journal of Cardio-Thoracic Surgery for complementary research.

Category:Elsevier academic journals Category:Cardiology journals Category:Transplantation journals Category:Monthly journals Category:Publications established in 1981